Dr. Shishir Seth

Dr. Shishir Seth
Hemato Oncologist, Delhi

MBBS, MD, DM

  • 1 Hospital
  • Dr. Shishir Seth is a consultant at Indraprastha Apollo Hospitals, Delhi
  • Worked as Consultant, - Hemato-oncology & Stem Cell Transplant (BMT), at Rajiv Gandhi Cancer Institute, New-Delhi
  • Worked as Fellow-Leukemia/Bone Marrow Transplantation Division Of Hematology, Vancouver General Hospital, Vancouver, BC, Canada
  • Worked as senior resident (DM-Clinical Hematology) at Seth G.S. Medical College & KEM hospital, Mumbai-India
  • Worked as consultant at Moolchand Hospital, New Delhi
  • Worked as Sr. Resident at GTB Hospital, New Delhi
  • Worked as Clinical assistant- Hematology at PD Hinduja National Hospital, Mumbai
  • Worked as Sr. AMO at Bombay Hospital, Mumbai
  • Worked as Junior resident at Seth G.S. Medical College & KEM hospital, Mumbai-India

Specialities

  • Hemato Oncology

  • Hematology

Conditions

  • Leukemia

  • Lymphoma

  • Multiple Myeloma

Expertise

  • Leukemia
  • Lymphoma 
  • Multiple Myeloma
  • Hematopoietic Stem Cell (Bone Marrow) Transplant

Education

  • MBBS, MD, DM

Practice Information

Indraprastha Apollo Hospitals, Delhi

Indraprastha Apollo Hospitals, Delhi

Sarita Vihar, Delhi Mathura Road, Delhi, Delhi - 110076

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Shishir Seth and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Worked as principal investigator for 2010DRL001: An investigator initiated observational study to evaluate the response rate and toxicity (safety) of the combination of bendamustine and rituximab (BR) in fresh adult chronic lymphocytic leukemia patients
  • Principal Investigator for IVPL_RT_01: A study of Rituximab in patients with Non Hodgkins Lymphoma a type of cancer
  • An unusual presentation of pediatric acute lymphoblastic leukemia. Indian J Hematol Blood Transfus, 2008; :24(2) 59-62
  • “Lymph node and Tuberculosis: Clinical, Pathological and Microbiological Correlation.” In CYTOCON-2003 at Pune, India
  • “Spectrum of small intestinal lymphoma in western India” in International conference on emerging trends in hematology and immunohematology at Mumbai, India
  • “Chronic Myeloid Leukemia: Demographic and clinical profile from a tertiary center in western India” in Leukemias: molecular insights to treatment paradigms at Mumbai
  • Hematopoietic Cell Transplantation in Lymphoma: Why & When; Evidence Based Review. Cancer News, Dec 2011;5(5) 10-12
  • Acute Myeloid Leukemia- An Update. RGCI Newsletter-External- Mar 2012; 16(3) 2-3
  • Autologous Stem Cell Transplantation in a patient with Burkitts Lymphoma and paraparesis. Rajeeb Kumar Deo; Prakash Chitalkar; Shishir Seth,; Kundan Chufal, Hilal Ahmed Yattoo, Abha Bhalla Poster presented at the 52 nd Annual Meeting of the Indian Society of Hematology and Transfusion Medicine, Chandigarh, November 11-13, 2011
  • Indian Society of Hematology and Transfusion Medicine (Life Member)
  • American Society of Clinical Oncology
  • American Society of Hematology